Product Description
More invaluable, reassuring, and current information about diagnosis, treatment options, and beyond Completely revised and updated to meet your changing needs, the editors have retained the widely praised aspects of the first and second editions, while incorporating new, state-of-theart information on breast cancer treatment. This comprehensive edition arms you with information for making educated health choices together with you… More >>
Most Still Not Getting Screened For Skin Cancer
Despite all of the constant warnings about the dangers of sun exposure, skin cancer cases continue to rise with more than 3.5 million new cases diagnosed every year.
Read more on WBZ Boston
“Ovarian cancer is typically diagnosed at an advanced stage when it is incurable, and the same treatments have been used for virtually all patients,” says Michael Birrer, MD, PhD, director of medical gynecologic oncology in the Massachusetts General Hospital (MGH) Cancer Center, the study’s corresponding author. “Previous research from my lab indicated that different types and grades of ovarian tumors should be treated differently, and this paper now shows that even papillary serous tumors have differences that impact patient prognosis.” Birrer was with the National Institutes of Health when this study began and joined the MGH Cancer Center.
The fifth most common malignancy among U.S. women, ovarian cancer is expected to cause close to 15,000 deaths during 2009. Accounting for 60 percent of ovarian cancers, papillary serous tumors are typically diagnosed after spreading beyond the ovaries. The tumors typically return after initial treatment with surgery and chemotherapy, but while some patients die a few months after diagnosis, others may survive five years or longer while receiving treatment.
» Read more: Possible Ovarian Cancer Treatment Target Identified